Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
Bone Marrow Transplantation|May 1, 1997
Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literatureJ R Mackey, S Desai, L Larratt, et al.Molecular Medicine Today|May 14, 1999
Nucleoside transporters: molecular biology and implications for therapeutic developmentS A Baldwin, J R Mackey, C E Cass, et al.Clinical Breast Cancer|March 20, 2002
Internet usage among women with breast cancer: an exploratory studyJ L Pereira, S Koski, J Hanson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2012
Targeting triple-negative breast cancer: optimising therapeutic outcomesK Gelmon, R Dent, J R Mackey, et al.Current Oncology (Toronto, Ont.)|June 23, 2016
Real-world adjuvant TAC or FEC-D for HER2-negative node-positive breast cancer in women less than 50 years of ageS Lupichuk, D Tilley, X Kostaras, et al.Current Oncology (Toronto, Ont.)|April 8, 2015
Systemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelinesA A Joy, M Ghosh, R Fernandes, et al.Electrophoresis|September 8, 2001
Biomonitoring of urinary tamoxifen and its metabolites from breast cancer patients using nonaqueous capillary electrophoresis with electrospray mass spectrometryS J Carter, X F Li, J R Mackey, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 19, 2017
Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 studyG Spera, R Fresco, H Fung, et al.Current Oncology (Toronto, Ont.)|June 19, 2018
Hormone receptor-positive, HER2-negative metastatic breast cancer: redrawing the linesA Matutino, A A Joy, C Brezden-Masley, et al.Molecular Membrane Biology|March 24, 1999
Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridineM W Ritzel, S Y Yao, A M Ng, et al.Pageof 7